Week 3: Acute and Chronic Respiratory Conditions in the Pediatric Client

Normal Pediatric Respiratory Anatomy and Physiology

  • Upper respiratory tract components (as summarized in the transcript): nasal passages, nasopharynx, epiglottis, larynx. These structures contain smooth muscle and mucous glands.

    • Transient upper airway sounds are heard

    • Infants aiway cartilage is soft

    • outh breather

    • Airway diameter is smaller

    • Difficult to ausculate due to a narrower airway and the presence of secretions, which can lead to challenges in diagnosing respiratory conditions effectively.

  • Lower respiratory tract components: trachea, carina, bronchi, bronchioles, alveolar space.

  • Alveoli: air sacs where oxygenation occurs via capillaries; alveolus structure supports gas exchange.

  • Visual cues on the slides included a cross-sectional view showing the airway from nasal/oral entry through bronchioles to alveoli; emphasis on airway mucous production and smooth muscle affecting patency.

  • Infant vs adult anatomy notes (e.g., tongue size and airway considerations) highlighted in the slide sequence; these influence airway patency in pediatrics.

    • Tongue is larger and can cause obstruction.

Respiratory Assessments and Manifestations

  • Key assessment domains: Respirations, Oxygenation, Observation, Auscultation.

  • Early manifestations vs later manifestations of respiratory distress should be differentiated; the dehydration status should be considered during assessment.

    • Signs of respiratory distress, such as tachypnea, retractions, and nasal flaring, may appear initially, while later signs can include cyanosis, altered mental status, and exhaustion.

      • Early manifestation: fuzzy or irritative, pallor.

      • Later: lethargic, tachypnic, and tachycardic, expect adventitious breath sounds, cyanosis.

        • Also, beware of their position (tripod), head bobbing (super concerning), and nasal flaring.

        • Higher retractions, more distressed. Shoulder usage.

      • Assess for skin color, pulse ox, and work of breathing to evaluate the severity of respiratory distress and to guide further intervention.

      • Children under 3 years of age are not able to blow their nose; therefore, suction is necessary.

      • First suction, then put them on oxygen in their nares (nasal cannula 4 L max), then if nothing changes, call the provider.

    • Are they dehydrated? Assessing hydration levels is crucial, as dehydration can exacerbate respiratory conditions and influence the overall clinical picture (such as crying with minimal tears)

    • Respiratory rate>60 is concerning, and the child would be NPO.

  • Pulse oximetry is a useful adjunct in infant assessment (image reference in slide).

    • Rotate sight to prevent skin ulcers.

Retractions and Severity of Respiratory Distress

  • Retractions: higher retractions denote greater airway compromise; observing and documenting severity is important.

        

  • Important nursing note: if an infant is not allowed to eat (NPO) and has a respiratory rate > 60 breaths per minute, this indicates SEVERE distress.

Acute Epiglottitis (Medical Emergency)

  • Etiology: Bacterial, usually Haemophilus influenzae type b (Hib influenzae).

  • Health Promotion/Maintenance considerations: Vaccination status relevant (Hib vaccine); Droplet precautions until stabilized.

  • Age/Onset: typically 2–5 years; progresses rapidly.

  • Expected findings: stridor, drooling, muffled voice, dysphagia; tripod position; chin protrusion; mouth open; tongue protruding; inflamed, large cherry-red epiglottis; respiratory distress; high fever.

    • Keep upright, in an undisturbed, comfortable position.

    • Do not put anything in their mouth or tongue to prevent obstructing their airway. NOTHING IN THEIR MOUTH.

    • Likely intubated.

    • No spontaneous cough, as they can’t clear their airway.

  • Therapeutic procedures/meds: possible endotracheal intubation or tracheostomy in severe cases; lateral neck X-ray; antibiotics; droplet precautions for 24 hours after IV antibiotics; corticosteroids; IV fluids; humidified oxygen.

  • Nursing interventions:

    • Do not insert anything in the mouth.

    • Position the child for comfort; provide calm reassurance to the caregiver and child.

    • Maintain droplet precautions.

    • Monitor vital signs and oxygenation status.

    • Have intubation equipment readily available at the bedside.

Acute Laryngotracheal Bronchitis (Croup)

  • Etiology: Viral (RSV, influenza A & B), mycoplasma pneumonia, measles, parainfluenza types 1–3.

    • Health promotion and maintenance, educate the client on vaccines.

  • Age/Onset: Infants and children <2 years; gradual onset.

  • Expected findings: inspiratory stridor, barky/brassy cough, hoarseness, restlessness, irritability, retractions, low-grade fever.

  • Therapeutic procedures/meds: cool air outside or cool mist (shocks the airway); steroids (oral/IV); racemic epinephrine (nebulized); nebulized budesonide.

  • Nursing interventions: frequent VS monitoring; be alert for airway obstruction/distress; provide reassurance; stay calm; caregiver support; hold child as needed.

    • Supportive care: oxygenation, fluids, and suctioning.

  • Hear stridor, give steroids and racemic epenephrine!

Acute Spasmodic Laryngitis

  • Etiology: Viral, possibly allergy-related.

  • Age/Onset: 1–3 years.

  • Pattern: child awakens at night with sudden dyspnea and barking metallic cough; stridor; hoarseness; restlessness; symptoms typically disappear during the day and recur.

  • Therapeutic procedures/meds: cool mist (shocks the airway); steroids; racemic epinephrine (nebulized); supportive care.

  • Nursing interventions: Often managed at home; use a cool mist vaporizer; encourage quiet activities at home.

Bronchitis and Bronchiolitis (RSV)

  • Bronchitis/Bronchiolitis often involves lower respiratory tract infection with cough and airway inflammation.

    • Bronchitis is common in kids under the age of 2, while bronchiolitis primarily affects infants and young children under 12 months.

  • Important note: cough suppressants may hinder clearance of secretions; care focuses on supportive management.

Bronchiolitis: Etiology and Assessment

  • Common etiologies: RSV (most common cause), parainfluenza, adenovirus.

  • Risk factors: males are more often affected; peak incidence is <7 months; under 2 years; prematurity; crowding; chronic disease; daycare; secondhand smoke exposure.

  • Expected findings: fever, cough, rhinorrhea/pharyngitis, irritability, respiratory distress, copious secretions, wheezing or crackles; possible eye/ear infections; dehydration signs.

    • Mental status change, adventitious breath sounds, tachypnea and tachycardia, lethargy.

  • Diagnostics/Labs: NP viral panel/NP wash; ABGs; electrolytes; rapid antigen testing (IF/ELISA).

    • Swab their nares for labs.

  • Therapeutic procedures: bronchodilators are generally not recommended; supportive care; ribavirin (for RSV as indicated); corticosteroids (sometimes); palivizumab (Synagis) for prevention in high-risk groups (premies from getting RSV).

    • Suction before feeds to prevent aspiration.

  • Nursing interventions: droplet and contact precautions; suction, repositioning, supplemental oxygen as needed; limit visitors; assign to RN with no other at-risk visitors; encourage fluids; avoid chest physiotherapy (not proven to be effective); education on handwashing, avoiding smoke exposure, suction technique with bulb syringe.

Otitis Media (Acute Otitis Media, AOM)

  • Contributing factors: age < 24 months; Cleft lip/palate; daycare exposure; passive smoke exposure; bottle propping; recent URI; allergies; enlarged lymph nodes; winter/spring season; incomplete immunizations; Down syndrome.

  • Expected findings: ear pain, fever, enlarged lymph glands, bulging tympanic membrane, inconsolable crying, poor appetite/sleep, purulent drainage if rupture; transient hearing loss.

  • Diagnostics/Meds/Therapeutic procedures: otoscopy, acoustic reflectometry, tympanometry; antibiotics (if bacterial infection), antipyretics/analgesics; topical anesthetics; myringotomy with tympanostomy tubes (BMTs) in select cases (to help drain).

  • Nursing interventions/education: explain pinna rationale; apply heat to affected ear; maintain dry ear with WET ear care; monitor for hearing loss; promote vaccine adherence; avoid bottle propping; avoid passive smoking; encourage breastfeeding; seek care when symptoms occur; BMT care includes keeping water out of the ear and notifying the provider when tubes extrude.

Tonsillitis and Tonsillectomy

  • Contributing factors: often in younger children.

    • Due to an underdeveloped immune system.

  • Expected findings: halitosis, snoring, nasal-sounding voice, mouth breathing, hearing difficulties, throat pain with swallowing, fever, persistent cough, breathing/swallowing difficulties.

  • Diagnostics/Therapeutics: throat culture; CBC; clotting times; antibiotics if strep positive; antipyretics; antiemetics; topical anesthetics; tonsillectomy if indicated.

  • Nursing interventions: diet considerations (soft/liquids); cool-mist vaporizer; warm saline gargles.

  • Tonsillectomy pre-operative care: consent, bleeding risk, URI symptoms, loose teeth; baseline VS.

    • Take note of CBC and clotting times.

  • Post-operative care: monitor for excessive bleeding (signs of swallowing difficulty, frequent throat clearing); airway assessment; elevate head of bed; NPO transitioning to clear/soft; around-the-clock analgesia; ice collar; patient education on discharge and when to seek help for bleeding, persistent cough, ear pain, or fever.

    • Complications: bleeding, pain, and dehydration.

      • Reposition for drainage.

    • Monitor for frequent clearing of the throat or swallowing.

      • If you see a child constantly coughing or clearing their throat, this is alarming and can be a sign of bleeding.

    • Avoid gargling and vigorous tooth brushing.

    • Avoid red dyes in their diet.

Pneumonia and Related Considerations

  • Pneumonia can be viral or bacterial; discuss possible complications and preventive strategies.

    • Upper respiratory infection

    • Risk of bacterial infection

      • Abrupt and suspect viral infection

      • If bacteria use antibiotics

      • Hib vaccine is a preventative measure.

  • In clinical notes, there is emphasis on infection control and monitoring for respiratory status changes.

Chronic Pulmonary Conditions in the Pediatric Client: Asthma and Cystic Fibrosis (CF)

  • Endocrine dysfuntion

Asthma: Pathophysiology and Course

  • Pathophysiology: chronic inflammatory process with IgE-mediated responses; involvement of mast cells, eosinophils, and T-lymphocytes leading to vascular congestion; bronchiolar hyperreactivity to irritants; intrinsic vs extrinsic triggers; bronchospasm and mucus production cause air trapping and hypoxemia.

    • Respiratory failure is the key thing you’re worried about.

    • Dehydration could be a factor.

  • Clinical course: exposure to environmental factors provokes airway inflammation; coughing, wheezing, chest tightness, and breathlessness may progress to airway hyper-responsiveness and obstruction, potentially leading to hypoxemia and respiratory failure if severe.

  • Key concepts: Chronic inflammation, airway remodeling, and variability in symptoms.

Asthma Classification (Four Categories)

  • Intermittent: Findings frequency 0-2 times per week; nighttime findings none for ages 0–4 years old or none or infrequent for older children; activity limitations none.

  • Mild Persistent: Frequency greater than intermittently but not daily; nighttime findings 1–2 times per month (0–4 years) or 3–4 times per month (5–11 years); minor activity limitations.

  • Moderate Persistent: Daily symptoms; nighttime findings more frequent (3–4 times per month for 0–4; frequent for older children); some activity limitations.

  • Severe Persistent: Continuous symptoms; nighttime findings frequent (more than once/week, but not daily for 0–4; frequent for older children); extreme activity limitations.

  • Use of Short-Acting Beta-Agonists (SABA) as rescue medication increases with greater severity.

    • Should not be used daily or multiple times a day. Need steroids to deal with it better.

Triggers of Asthma

  • Extrinsic triggers (allergens): pollen, dust mites, mold, animal dander, cockroaches, etc.

    • Know to keep children away from this.

  • Intrinsic triggers (nonallergic): exercise, cold air, irritants (smoke, strong odors), viral infections, irritants in the environment.

    • An increase in women due to hormonal changes during menses.

Asthma Expected Findings and Diagnostics

  • Typical symptoms: dyspnea, cough, inspiratory and/or expiratory wheeze; decreased air movement is a concern even if wheezing is absent.

  • Diagnostics: age-appropriate assessment plus tests such as chest X-ray, pulmonary function tests (PFTs), Peak Expiratory Flow Rate (PEFR), CBC, and pulse oximetry.

  • PEFR details: PEFR measures the maximum flow of air that can be forcibly exhaled in one second. Measured using a peak expiratory flow meter (PEFM) in L/min. Each child should establish their personal best, measured over 2-3 weeks when asthma is stable.

  • A chronic cough with no infection or expiratory wheezing can support a diagnosis.

Therapeutic Procedures / Medications (Asthma)

  • Bronchodilators:

    • Short-Acting Beta-2 Agonists (SABA)

      • Heart and lungs

      • Tachycardia

    • Long-Acting Beta-2 Agonists (LABA)

      • Controllers

    • Distinguish rescue meds from long-term control meds.

  • Cholinergic antagonists (anticholinergics).

  • Allergen control strategies.

  • Anti-inflammatory agents (e.g., corticosteroids).

  • Leukotriene modifiers.

  • Mast cell stabilizers.

    • Good controllers for allergies.

  • Monoclonal antibodies.

  • Combination medications.

  • Emergency measures: Magnesium sulfate (need to call a rapid response, bolus of fluid needed due to low BP that could happen); Oxygen; IV fluids; ABGs; BMP; high potassium diet (note: referenced in slide as part of emergency management).

  • Complications to monitor: Status asthmaticus (medical emergency), respiratory failure.

  • Nursing interventions/education:

    • Frequent assessments before and after treatments.

      • Auscultate the heart and respiratory rate before and after treatment.

      • If the child is very tachycardic, then spread out treatment to address this.

    • Use of spacers with metered-dose inhalers (MDIs).

    • Rinse the mouth after inhaled steroids or other inhaled meds to prevent candidiasis.

Review Questions and Clinical Scenarios (Asthma)

  • Example ER scenario: In a 10-year-old with acute asthma exacerbation, worsening condition is indicated by increased wheezing vs decreased wheezing, among other signs. (Slide prompts to distinguish signs of worsening.)

  • Poster/presentation review questions address inflammation, airway swelling, and the timing of bronchial narrowing during bronchospasm; most children with chronic asthma have allergies is a common statement in review prompts.

  • Controller therapy teaching: when a child is instructed after taking controller medication, suggest actions such as rinsing the mouth after inhaler use.

Cystic Fibrosis (CF): Pathophysiology and Systems Involved

  • CF is a multi-system disease characterized by thick, sticky mucus production due to defective chloride transport in sweat glands and exocrine glands.

  • Contributed factors: family history, which is seen heavily amongst Caucasian clients.

    • Higher risk for sepsis!

    • Decreased immune system, increased chances of infection.

      • PICC line or VAC for IV antibiotic meds.

  • Organs affected (cross-sectional view):

    • Lungs: thick mucus buildup, bacterial infections, widened airways; risk of bronchiectasis, bronchitis, bronchiolitis, pneumonia, atelectasis, pneumothorax, bronchial obstruction due to mucus.

    • Sinuses: sinusitis, nasal polyps.

    • Liver: hepatic steatosis, portal hypertension, biliary cirrhosis, neonatal obstructive jaundice, cholelithiasis.

    • Pancreas: blocked pancreatic ducts leading to malabsorption and fat-soluble vitamin deficiency; pancreatitis; insulin deficiency.

    • intestines: meconium ileus in newborns, distal intestinal obstruction syndrome, rectal prolapse, malabsorption issues.

    • Reproductive: infertility (aspermia or absent vas deferens in males; amenorrhea and delayed puberty in females).

  • Skin: sweat glands produce salty sweat; tears/saliva also high in sodium and chloride.

  • Growth and nutrition: poor weight gain, failure to thrive due to malabsorption; fat-soluble vitamin deficiencies (A, D, E, K).

CF Diagnostics

  • Nutritional panel (fat-soluble vitamin levels A, D, E, K)

  • Sputum culture, chest and abdominal X-rays

  • DNA testing, Sweat chloride testing

  • Pulmonary function tests (PFTs)

  • Stool analysis

CF Therapeutic Procedures and Medications

  • Respiratory and supportive care:

    • Oxygen, IV fluids, feeding tube as needed.

    • High-protein, high-calorie diet.

    • Chest physiotherapy (CPT) for airway clearance; airway clearance therapy (ACT) 2x daily or more as ordered; CPT is performed to loosen mucus.

      • May use a vest chest PT, do not eat after use, as there is the chance of emesis.

    • Vaccines and RSV prevention: Palivizumab.

    • Pancreatic enzyme replacement within 30 minutes of meals.

    • Dornase alfa (DNase) to decrease mucus viscosity.

    • Multivitamins; fat-soluble vitamin supplementation; antibiotics/antifungals.

    • H2 blockers and PPIs as needed; stool softeners as needed.

    • Transplant options (lung, heart, pancreas) in end-stage disease; liver transplant in some CF-related situations; also consideration of bowel transplant in select cases.

CF Nursing Interventions

  • Frequent respiratory assessments; daily weight checks.

  • Involve the child and caregiver in care planning.

  • Airway clearance therapy (ACT) 2x daily or more as ordered; CPT as prescribed.

  • Maintain a high-protein, high-calorie diet with snacks; moderate aerobic exercise.

  • Monitor glucose for CFRD (CF-related diabetes).

  • Education and psychosocial support for the patient and family.

    • Educate the family on having their child meet their caloric needs, the definition of the disease process, and how to react to it (when to give meds, non-therapeutic methods).

  • Dietary counseling and coordination of care.

CF Complications and General Manifestations

  • Respiratory: bacterial/fungal colonization, bronchiectasis, recurrent infections, pneumothorax, atelectasis, hemoptysis, bronchiolitis, bronchitis, etc.

  • Hematologic/vascular: pulmonary hypertension, cor pulmonale in advanced disease.

  • Liver and biliary: hepatic steatosis, portal hypertension, biliary cirrhosis.

  • Gastrointestinal and nutrition: meconium ileus in neonates, pancreatic insufficiency with malabsorption, and malnutrition.

  • Growth and developmental: failure to thrive, growth delays.

    • Daily weight due to the failure to thrive.

CF Diet and Nutrition Counseling

  • CF patients require high-calorie, high-protein diets with adequate salt intake to offset salt losses in sweat.

  • Salt intake considerations: sweat and tears can be salty; ensure electrolyte balance is maintained.

Diet and Education Scenarios (CF Nutrition Question)

  • Typical exam question: A CF patient should be advised to consume foods high in calories and protein to meet higher energy needs; salt intake should be managed to prevent hyponatremia in sweat-rich states.

Practical Nursing Implications and Distinguishing Features

  • Early recognition of distress in pediatric respiratory conditions is critical for timely intervention.

  • Infection control measures (droplet and contact precautions) are essential in epiglottitis, bronchiolitis, and other infectious etiologies.

  • Family education is central: suction techniques, hand hygiene, vaccination adherence, avoidance of tobacco smoke, and recognition of warning signs of deterioration.

  • For CF, multi-system involvement requires coordinated care focusing on nutrition, airway clearance, infection control, and monitoring for CFRD and liver/pancreatic complications.